Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001042720 | SCV001206420 | uncertain significance | Primary dilated cardiomyopathy | 2019-12-31 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Asp896Glyfs*11) in the NEBL gene. It is expected to result in an absent or disrupted protein product. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the ExAC database. This variant has not been reported in the literature in individuals with NEBL-related conditions. The current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in NEBL cause disease. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |